Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRT-SCI Trial
NCT07742553Phase 3Not yet recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Oct 2027
- Primary completion
- Sep 2031
- Countries
- 1
01
Overview
A Phase 3 trial of testosterone cypionate, finasteride in spinal cord injury (SCI), Hypogonadism, sponsored by VA Office of Research & Development. Planned start Oct 2027; status: not yet recruiting.
02
Drugs
testosterone cypionatefinasteride
03
Conditions
spinal cord injury (SCI)Hypogonadism
Beyond the preview
Go deeper on NCT07742553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07742553.